| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8938989 | British Journal of Anaesthesia | 2007 | 7 Pages |
Abstract
Although both TIVA and dolasetron prophylaxis reduce the predicted rate of PONV in the early postoperative period, the anti-emetic effects of propofol are short-lived. A longer-acting drug such as dolasetron may therefore be necessary to prevent PDNV.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
H. White, R.J. Black, M. Jones, G.C. Mar Fan,